Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000169450 | SCV001146739 | pathogenic | Phenylketonuria | 2019-02-26 | reviewed by expert panel | curation | Pathogenic: The c.58C>T (p.Gln20Ter) is a null variant reported in one patient with classic PKU phenotype (PVS1, PP4, PMID: 9391881). This variant is absent from population databases, including gnomAD, 1000 Genomes, and ESP (PM2). In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PP4. |
Counsyl | RCV000169450 | SCV000220871 | likely pathogenic | Phenylketonuria | 2014-11-12 | criteria provided, single submitter | literature only | |
Ce |
RCV000088993 | SCV001250403 | pathogenic | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000169450 | SCV001370580 | pathogenic | Phenylketonuria | 2020-05-25 | criteria provided, single submitter | clinical testing | Variant summary: PAH c.58C>T (p.Gln20X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251430 control chromosomes. c.58C>T has been reported in the literature in multiple individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria) (example, Kozak_1997, Guldberg_1998, Quirk_2012, Djordjevic_2013, Polak_2013, Reblova_2013). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory and one expert panel (ClinGen) have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. |
Labcorp Genetics |
RCV000169450 | SCV001400667 | pathogenic | Phenylketonuria | 2024-05-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln20*) in the PAH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PAH are known to be pathogenic (PMID: 1301187, 9634518). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with phenylketonuria (PKU) (PMID: 9391881, 23357515, 23430547, 23764561, 27121329). ClinVar contains an entry for this variant (Variation ID: 102744). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV000088993 | SCV002512913 | pathogenic | not provided | 2021-05-24 | criteria provided, single submitter | clinical testing | Reported in multiple individuals with classic phenylketonuria (PKU) or mild hyperphenylalaninemia (HPA) in the presence of a second pathogenic variant (Stojiljkovic et al., 2006; Quirk et al., 2012); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Responsiveness to BH4 therapy is unclear (Djordjevic et al., 2013); This variant is associated with the following publications: (PMID: 23357515, 27121329, 1301187, 25525159, 9284280, 9391881, 23764561, 23430547, 9634518, 16879198, 22841515, 32668217) |
Baylor Genetics | RCV000169450 | SCV005053825 | pathogenic | Phenylketonuria | 2024-02-21 | criteria provided, single submitter | clinical testing | |
De |
RCV000088993 | SCV000119597 | not provided | not provided | no assertion provided | not provided |